Decision flexibilities in autism spectrum disorder: an fMRI study of moral dilemmas.

autism spectrum disorder flexibility functional magnetic resonance imaging inferior frontal gyrus moral dilemma

Journal

Social cognitive and affective neuroscience
ISSN: 1749-5024
Titre abrégé: Soc Cogn Affect Neurosci
Pays: England
ID NLM: 101288795

Informations de publication

Date de publication:
03 10 2022
Historique:
received: 28 08 2021
revised: 07 02 2022
accepted: 24 03 2022
pubmed: 26 3 2022
medline: 5 10 2022
entrez: 25 3 2022
Statut: ppublish

Résumé

People make flexible decisions across a wide range of contexts to resolve social or moral conflicts. Individuals with autism spectrum disorder (ASD) frequently report difficulties in such behaviors, which hinders the flexibility in changing strategies during daily activities or adjustment of perspective during communication. However, the underlying mechanisms of this issue are insufficiently understood. This study aimed to investigate decision flexibility in ASD using a functional magnetic resonance imaging task that involved recognizing and resolving two types of moral dilemmas: cost-benefit analysis (CBA) and mitigating inevitable misconducts (MIM). The CBA session assessed the participants' pitting of result-oriented outcomes against distressful harmful actions, whereas the MIM session assessed their pitting of the extenuation of a criminal sentence against a sympathetic situation of defendants suffering from violence or disease. The behavioral outcome in CBA-related flexibility was significantly lower in the ASD group compared to that of the typical development group. In the corresponding CBA contrast, activation in the left inferior frontal gyrus was lower in the ASD group. Meanwhile, in the MIM-related flexibility, there were no significant group differences in behavioral outcome or brain activity. Our findings add to our understanding of flexible decision-making in ASD.

Identifiants

pubmed: 35333369
pii: 6554182
doi: 10.1093/scan/nsac023
pmc: PMC9527470
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

904-911

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press.

Références

JAMA. 2003 Jul 2;290(1):86-97
pubmed: 12837716
Wiley Interdiscip Rev Cogn Sci. 2011 Jan;2(1):55-67
pubmed: 26301913
Trends Cogn Sci. 2009 Feb;13(2):74-82
pubmed: 19138551
J Autism Dev Disord. 2006 Feb;36(2):263-70
pubmed: 16586157
Brain Res. 2006 Mar 24;1079(1):86-97
pubmed: 16490183
Hum Brain Mapp. 2020 Apr 15;41(6):1677-1688
pubmed: 31854496
Neurosci Biobehav Rev. 2014 Nov;47:520-32
pubmed: 25454356
Sci Rep. 2017 Jul 25;7(1):6415
pubmed: 28743978
Transl Psychiatry. 2015 Aug 25;5:e625
pubmed: 26305476
Nat Rev Neurosci. 2012 Sep;13(9):636-50
pubmed: 22903221
Trends Cogn Sci. 2019 Mar;23(3):174-186
pubmed: 30679099
Mol Autism. 2017 Aug 16;8:45
pubmed: 28824795
Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4385-4391
pubmed: 32041879
Neuron. 2010 Aug 26;67(4):667-77
pubmed: 20797542
PLoS Biol. 2007 Apr;5(4):e103
pubmed: 17439297
Biol Psychiatry. 2021 Jan 15;89(2):172-183
pubmed: 32709415
Nat Commun. 2012 Mar 27;3:759
pubmed: 22453832
Cognition. 2008 Aug;108(2):381-417
pubmed: 18486121
Neurosci Res. 2015 Jan;90:15-24
pubmed: 25455743
Neurosci Biobehav Rev. 2017 Dec;83:132-139
pubmed: 29032087
Sci Rep. 2018 May 24;8(1):8082
pubmed: 29795394
Cereb Cortex. 2020 Nov 3;30(12):6458-6468
pubmed: 32770189
J Neurosci. 2021 Feb 24;41(8):1699-1715
pubmed: 33158960
Soc Cogn Affect Neurosci. 2016 Jan;11(1):100-9
pubmed: 26203050
Soc Cogn Affect Neurosci. 2013 Oct;8(7):780-8
pubmed: 22689217
Annu Rev Psychol. 2008;59:255-78
pubmed: 18154502
Neurosci Biobehav Rev. 2012 Feb;36(2):901-42
pubmed: 22101112
Philos Trans R Soc Lond B Biol Sci. 2012 Mar 5;367(1589):754-62
pubmed: 22271790
Neuroimage. 2002 Jan;15(1):273-89
pubmed: 11771995
Sci Rep. 2016 Sep 09;6:33171
pubmed: 27611212
Neuron. 2004 Oct 14;44(2):389-400
pubmed: 15473975
Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17433-8
pubmed: 20876101
Neuroimage. 2003 Jul;19(3):1233-9
pubmed: 12880848
Dev Psychopathol. 2020 Aug;32(3):1069-1085
pubmed: 31489833
Exp Clin Psychopharmacol. 2003 Feb;11(1):26-33
pubmed: 12622341
Neuropsychopharmacology. 2021 Feb;46(3):614-621
pubmed: 33040092
Trends Cogn Sci. 2007 Aug;11(8):319-21
pubmed: 17602852
J Autism Dev Disord. 2012 Jul;42(7):1364-76
pubmed: 21960456
Front Aging Neurosci. 2017 May 04;9:127
pubmed: 28522971
Trends Neurosci. 2015 Sep;38(9):571-8
pubmed: 26343956
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2688-92
pubmed: 21282628
Trends Cogn Sci. 2007 Aug;11(8):322-3; author reply 323-4
pubmed: 17625951
J Autism Dev Disord. 2013 Feb;43(2):458-70
pubmed: 22760338
Transl Psychiatry. 2014 Jun 03;4:e393
pubmed: 24893064
Eur Neuropsychopharmacol. 2018 Dec;28(12):1371-1381
pubmed: 30243683
Cereb Cortex. 2019 May 1;29(5):1984-1996
pubmed: 29668865
Autism Res. 2019 Nov;12(11):1598-1608
pubmed: 31102339
Neurosci Res. 2019 Jul;144:67-70
pubmed: 30107204
J Autism Dev Disord. 2015 Nov;45(11):3405-8
pubmed: 26391886
Soc Cogn Affect Neurosci. 2020 Sep 24;15(7):709-723
pubmed: 32608498
J Autism Dev Disord. 2019 Jan;49(1):1-10
pubmed: 30014249
Front Behav Neurosci. 2016 Apr 12;10:67
pubmed: 27147990
Soc Cogn Affect Neurosci. 2013 Aug;8(6):702-10
pubmed: 22569187
Soc Cogn Affect Neurosci. 2022 Feb 3;17(1):131-141
pubmed: 32412085
Proc Biol Sci. 2012 Aug 7;279(1740):3027-34
pubmed: 22496188
Soc Cogn Affect Neurosci. 2020 May 11;15(2):135-149
pubmed: 32163158
Soc Cogn Affect Neurosci. 2021 Aug 5;16(8):772-781
pubmed: 32483611
Biol Psychiatry. 2016 Feb 1;79(3):165-73
pubmed: 25908497
J Autism Dev Disord. 2001 Feb;31(1):5-17
pubmed: 11439754
Transl Psychiatry. 2016 Oct 11;6(10):e916
pubmed: 27727243
J Autism Dev Disord. 2019 May;49(5):1807-1824
pubmed: 30610668
Psychiatry Clin Neurosci. 2006 Jun;60(3):332-9
pubmed: 16732750
Trends Cogn Sci. 2021 Aug;25(8):685-696
pubmed: 34226128
Proc Biol Sci. 2005 Sep 22;272(1575):1865-75
pubmed: 16191591
Cognition. 2011 Oct;121(1):115-26
pubmed: 21745661
Front Psychol. 2016 Sep 27;7:1478
pubmed: 27729894
Trends Neurosci. 2017 Jan;40(1):15-27
pubmed: 27986294
Eur Arch Psychiatry Clin Neurosci. 2020 Dec;270(8):1063-1071
pubmed: 31559528

Auteurs

Shisei Tei (S)

Medical Institute of Developmental Disabilities Research, Showa University, Setagaya-ku, Tokyo 157-8577, Japan.
Department of Psychiatry, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan.
Institute of Applied Brain Sciences, Waseda University, Tokorozawa, Saitama 359-1192, Japan.
School of Human and Social Sciences, Tokyo International University, Kawagoe, Saitama 350-1198, Japan.

Mizuki Tanicha (M)

Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8510, Japan.

Takashi Itahashi (T)

Medical Institute of Developmental Disabilities Research, Showa University, Setagaya-ku, Tokyo 157-8577, Japan.

Yuta Y Aoki (YY)

Medical Institute of Developmental Disabilities Research, Showa University, Setagaya-ku, Tokyo 157-8577, Japan.

Haruhisa Ohta (H)

Medical Institute of Developmental Disabilities Research, Showa University, Setagaya-ku, Tokyo 157-8577, Japan.
Department of Psychiatry, School of Medicine, Showa University, Setagaya-ku, Tokyo 157-8577, Japan.

Chenyu Qian (C)

Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8510, Japan.

Ryu-Ichiro Hashimoto (RI)

Medical Institute of Developmental Disabilities Research, Showa University, Setagaya-ku, Tokyo 157-8577, Japan.
Department of Language Sciences, Graduate School of Humanities, Tokyo Metropolitan University, Hachioji-shi, Tokyo 192-0397, Japan.

Motoaki Nakamura (M)

Medical Institute of Developmental Disabilities Research, Showa University, Setagaya-ku, Tokyo 157-8577, Japan.
Kanagawa Psychiatric Center, Yokohama, Kanagawa 233-0006, Japan.

Hidehiko Takahashi (H)

Medical Institute of Developmental Disabilities Research, Showa University, Setagaya-ku, Tokyo 157-8577, Japan.
Department of Psychiatry, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan.
Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8510, Japan.

Nobumasa Kato (N)

Medical Institute of Developmental Disabilities Research, Showa University, Setagaya-ku, Tokyo 157-8577, Japan.

Junya Fujino (J)

Medical Institute of Developmental Disabilities Research, Showa University, Setagaya-ku, Tokyo 157-8577, Japan.
Department of Psychiatry, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan.
Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8510, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH